Skip to main content
Explore URMC
URMC / Labs / Cancer Control & Psychoneuroimmunology Lab / Research Projects / Current and Recent Projects Supported by the Lab


Current and Recent Projects Supported by the Lab

URMC Collaborators

Collaborators Conducting K Awards or pilot studies in the CCPL with Dr. Janelsins’ mentorship

Main External Collaborators

  • Dr. Oxana Palesh Stanford University
  • Dr. Shelli Kesler MD Anderson
  • Dr. Tim Ahles MSKCC
  • Dr. Debra Barton University of Michigan
  • Dr. Christina Ambrosone Roswell Park Cancer Institute
  • Dr. Sang Yao Roswell Park Cancer Institute

Current Projects Supported by the Lab:

Name of Project Funding Agency PI
Neurobehavior in Chemotherapy
Animal Models I
NIH Innovator DP2  Michelle Janelsins, Ph.D., MPH
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Impairment NCI K07 Michelle Janelsins, Ph.D., MPH
Biobanking Infrastructure Supplement  UG1 Supplement Michelle Janelsins, Ph.D., MPH
Exercise for Chemotherapy-Related Cognitive Impairment in Colorectal
Cancer Patients.
NCI R21 Michelle Janelsins, Ph.D., MPH
Assessment of Cognitive Function in
Breast Cancer and Lymphoma Patients Receiving Chemotherapy At Pre-Treatment, Post-Treatment, and Six Month Follow-Up
UG1 Supplement Michelle Janelsins, Ph.D., MPH
Geriatric Oncology Research to Improve Outcomes of Frail Adults with Cancer JPWCI Michelle Janelsins, Ph.D., MPH
University of Rochester –
NCORP Research Base.
NIH/NCI UG1 Gary Morrow, Ph.D., MS
R25 Cancer Control Research Training Grant  NIH R25 Gary Morrow, Ph.D., MS
A Randomized Clinical Trial Comparing
the Effectiveness of Yoga, Survivorship Health Education, and Cognitive
Behavioral Therapy for Treating Insomnia
in Cancer Survivors
NCI R01 Karen Mustian, Ph.D., MPH
A Study of the Effects of Exercise on Cancer-related Fatigue NCI R01 Supplement Karen Mustian, Ph.D., MPH
Cancer- Related Fatigue and Cognitive Impairment: An Investigation of Possible Biological Mechanisms Related to Exercise, Gene Expression, Protein Synthesis, Muscle Function and Inflammation UG1 Supplement Karen Mustian, Ph.D., MPH
Management of Cancer-Treatment-Induced Bone Loss in Breast Cancer Patients NCI K07 Luke Peppone, Ph.D., MPH
High-dose Vitamin D Supplementation for ADT-induced Side Effects NCI R21 Luke Peppone, Ph.D., MPH
Feasibility of Omega-3 Supplementation
for Cancer-related Fatigue



Luke Peppone, Ph.D., MPH


Inflammatory Mechanisms Underlying Supplementation with ω-3 Polyunsaturated Fatty Acids for Cancer-Related Fatigue
and Cognitive Impairment
UG1 Supplement Luke Peppone, Ph.D., MPH
Exercise for Lesbian, Gay, Bisexual, and Transgender Cancer Survivors. NCI K07 Charles Kamen, Ph.D., MPH
Risk Prediction for Development of
Adverse Effects Following Radiotherapy
For Prostate Cancer
NCI K07 Sarah Kerns, Ph.D., MPH 
Cognitive rehabilitation (CR) For at risk Older Cancer Patients Receiving Chemotherapy Department of Medicine Grant Allison Magnuson, DO
Examining the role of Clara Cell Secretory Protein as a Clinical Marker for Radiation-induced Lung Injury in Lung Cancer Patients Receiving Radiotherapy JPWCI Anita Peoples, Ph.D.
Utilizing New Tools To Improve Population Health ECRIP Career Development Chunkit Fung, MD
Pre-Habilition Exercise Intervention for Colorectal  Cancer Patients Receiving Chemotherapy Wilmot Fellowship  Fergal Fleming, MD 
Cancer-Related Cognitive Impairment in Leukemia Survivors after Treatment and
the Role of Inflammation
NIH F31/F99/K00 (pending)  Annalynn Williams, M.S. (student PI)